Roberts, Glore & Co’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
3,190
-765
-19% -$55.8K 0.06% 214
2026
Q1
$258K Sell
3,955
-788
-17% -$58.5K 0.07% 186
2025
Q4
$376K Sell
4,743
-5,463
-54% -$418K 0.1% 154
2025
Q3
$745K Sell
10,206
-60
-0.6% -$4.4K 0.2% 102
2025
Q2
$779K Sell
10,266
-50
-0.5% -$3.54K 0.23% 101
2025
Q1
$784K Hold
10,316
0.24% 93
2024
Q4
$681K Hold
10,316
0.2% 107
2024
Q3
$719K Buy
10,316
+475
+5% +$28.6K 0.21% 102
2024
Q2
$520K Buy
+9,841
New +$597K 0.16% 119

Other funds holding SOLV

Roberts, Glore & Co's SOLV Position: Q2 2026 in Review

Roberts, Glore & Co reduced its Solventum (SOLV) stake by 19% in Q2 2026, selling an estimated $55.8K and leaving 3,190 shares worth $246K. The position accounts for 0.06% of the portfolio, ranked #214.

Roberts, Glore & Co first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $784K in Q1 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Roberts, Glore & Co held 3,190 shares of Solventum worth $246K as of Q2 2026.
  • Roberts, Glore & Co sold 765 Solventum shares in Q2 2026, an estimated $55.8K.
  • Solventum made up 0.06% of Roberts, Glore & Co's portfolio in Q2 2026, its #214 holding.
  • Roberts, Glore & Co first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Roberts, Glore & Co's Solventum position peaked at $784K in Q1 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.